Tuberculosis News and Research

Latest Tuberculosis News and Research

Scientists use paleogenomics to trace 10,000 years of human immune system evolution

Scientists from the Institut Pasteur, Université Paris Cité, the CNRS and the Collège de France have used paleogenomics to trace 10,000 years of human immune system evolution.

13 Jan 2023

Researchers review bacteriophage treatment

Researchers presented an overview of bacteriophage treatment, including mechanisms, types, design and applications of bacteriophage therapy.

10 Jan 2023

Vitamin D can help the immune system fight tuberculosis, study says

Most people probably associate tuberculosis with a leaky loft in 20th-century Paris. But as a matter of fact, tuberculosis is not ancient history.

6 Jan 2023

People with latent tuberculosis infection could be at a higher risk for cardiovascular disease

Newly published research from the University of Cincinnati finds that people with latent tuberculosis infection (LTBI) have more inflammation and could be at a higher risk for cardiovascular disease.

6 Jan 2023

Exploring the immune mechanism induced by BCG vaccine in humanized mouse model

Announcing a new article publication for Zoonoses journal. This study was aimed at screening differentially expressed genes (DEGs) and exploring the potential immune mechanism induced by the Bacillus Calmette-Guerin (BCG) vaccine in a humanized mouse model.

3 Jan 2023

Salk scientists show how a microprotein can increase appetite in mice

Obesity and metabolic diseases, such as diabetes, are extremely common in the United States. Tiny proteins called microproteins have long been overlooked in research, but new evidence demonstrates that they have an important role in metabolism.

3 Jan 2023

Bacterial outer membrane vesicles: utility as vaccines and novel engineering approaches

Scientists have described the utility of gram-negative bacteria-derived outer membrane vesicles as vaccines and methods to expand their applications.

3 Jan 2023

Diagnostic technologies in Asia Pacific are key to progress toward health-related SDGs

We are at the halfway point from when we set our ambitious sustainable development goal 3 (SDG3) for good health and well-being by 2030.

23 Dec 2022

UMass Amherst microbiologist receives NIH grant to develop more effective treatments for tuberculosis

A microbiologist at the University of Massachusetts Amherst has received a National Institutes of Health grant to support research aimed ultimately at developing new, more effective treatments for tuberculosis (TB).

21 Dec 2022

WHO releases a global strategy for infection prevention and control at the 75th World Health Assembly

A recent draft released by the World Health Organization discussed the new global strategy to address the gaps in infection prevention and control (IPC) programs that became apparent after the coronavirus disease 2019 (COVID-19) pandemic.

21 Dec 2022

Newly designed antibiotic effective against multidrug-resistant bacteria

Researchers have designed and synthesized analogs of a new antibiotic that is effective against multidrug-resistant bacteria, opening a new front in the fight against these infections.

20 Dec 2022

Immune-evading Mycobacterium tuberculosis prevents inflammatory responses by hijacking the host’s ubiquitin

A new study discussed the findings of Chai et al., which revealed that triple specificity protein phosphatase (ptpB) secreted by Mycobacterium tuberculosis inhibits pyroptosis and the release of cytokines by macrophages, allowing M. tuberculosis to invade the immune system.

19 Dec 2022

Genome assembly tool could spur the development of new treatments for tuberculosis

Researchers have developed a novel genome assembly tool that could spur the development of new treatments for tuberculosis and other bacterial infections.

16 Dec 2022

FIU researchers awarded a U.S. patent for devising methods to synthesize new arsenic-based antibiotic

Florida International University researchers have moved a step closer to producing synthetic arsenic-based drugs in their quest to solve an urgent worldwide health problem -the growing number of infections that have become antibiotic-resistant.

16 Dec 2022

Severe undernutrition increases risk of unfavorable outcomes for individuals undergoing TB treatment

In 2021, an estimated 10.6 million individuals developed tuberculosis (TB) and 1.6 million died, making it the second most lethal infection in the world after SARS-CoV-2.

30 Nov 2022

Powerful imaging tool creates 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions

Gross anatomy reveals three-dimensional shapes of pathology at a large scale. Histology, in contrast, reveals the microscopic anatomy of biological structures. But that magnification comes at a cost -; histology shows only two-dimensional shapes because it studies small, flat slices of stained tissue.

29 Nov 2022

How SARS-CoV-2 immune responses vary by population due to environmental and genetic factors

Researchers investigate the genetic, immunological, and evolutionary factors that determine the vast variability observed in clinical manifestations of COVID-19.

28 Nov 2022

How national programs leveraged PEPFAR-supported laboratory resources for SARS-CoV-2 testing during the COVID-19 pandemic

Researchers described ways in which national-level programs leveraged PEPFAR [president’s emergency plan for acquired immunodeficiency syndrome (AIDS) relief]-aided laboratory-based resources for SARS-CoV-2 testing during COVID-19.

24 Nov 2022

New EULAR recommendations for screening and treating infections in AIIRD patients

It is already known that people who are immunocompromised are more prone to infections. Chronic and opportunistic infections are often found in people with an AIIRD, and may be linked to some of the immunosuppressive and immunomodulatory treatments used to treat these rheumatic diseases.

22 Nov 2022

Exploring antibiotic resistance in the EU

Antibiotic resistance is one of the greatest threats to global human health and to development.

22 Nov 2022

Tuberculosis News and Research

Latest Tuberculosis News and Research

Scientists use paleogenomics to trace 10,000 years of human immune system evolution

Researchers review bacteriophage treatment

Vitamin D can help the immune system fight tuberculosis, study says

People with latent tuberculosis infection could be at a higher risk for cardiovascular disease

Exploring the immune mechanism induced by BCG vaccine in humanized mouse model

Salk scientists show how a microprotein can increase appetite in mice

Bacterial outer membrane vesicles: utility as vaccines and novel engineering approaches

Diagnostic technologies in Asia Pacific are key to progress toward health-related SDGs

UMass Amherst microbiologist receives NIH grant to develop more effective treatments for tuberculosis

WHO releases a global strategy for infection prevention and control at the 75th World Health Assembly

Newly designed antibiotic effective against multidrug-resistant bacteria

Immune-evading Mycobacterium tuberculosis prevents inflammatory responses by hijacking the host’s ubiquitin

Genome assembly tool could spur the development of new treatments for tuberculosis

FIU researchers awarded a U.S. patent for devising methods to synthesize new arsenic-based antibiotic

Severe undernutrition increases risk of unfavorable outcomes for individuals undergoing TB treatment

Powerful imaging tool creates 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions

How SARS-CoV-2 immune responses vary by population due to environmental and genetic factors

How national programs leveraged PEPFAR-supported laboratory resources for SARS-CoV-2 testing during the COVID-19 pandemic

New EULAR recommendations for screening and treating infections in AIIRD patients

Exploring antibiotic resistance in the EU

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Tuberculosis News and Research

Latest Tuberculosis News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in